INVARIANT NAURURAL KILLER T CELLS: A NEW PLAYER IN THE PATHOGENESIS OF ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0

作者：

Smith, Edward ^{[1
]}

Croca, Sara ^{[1
]}

Waddington, Kirsty ^{[1
,2
]}

Isenberg, David ^{[1
]}

Torra, Ines Pineda ^{[2
]}

Rahman, Anisur ^{[1
]}

Jury, Elizabeth C. ^{[1
]}

机构：

[1] UCL, Ctr Rheumatol Res, London, England

[2] UCL, Ctr Clin Pharmacol, London, England

来源：

RHEUMATOLOGY | 2016年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

I41

引用

页码：8 / 8

页数：1

共 50 条

[31] Atherosclerosis and level of biomarkers in patients with systemic lupus erythematosus [J].

Movsesyan, Anastasiya ;

Kirillova, Irina ;

Semashko, Anna ;

Potapova, Alena ;

Karateev, Roman ;

Gerasimova, Elena ;

Bogatyreva, Anastasia .

ATHEROSCLEROSIS, 2025, 407

[32] Progression of carotid atherosclerosis in patients with systemic lupus erythematosus [J].

Rosa W. Telles ;

Cristina C. D. Lanna ;

Adriano J. Sousa ;

Tulio P. Navarro ;

Fabiana L. Souza ;

Luciana A. Rodrigues ;

Rodrigo C. P. Reis ;

Antonio L. Ribeiro .

Clinical Rheumatology, 2013, 32 :1293-1300

[33] Systemic lupus erythematosus: Atherosclerosis confined to patients with nephritis [J].

McHugh J. .

Nature Reviews Rheumatology, 2017, 13 (6) :322-322

[34] Pathogenesis and new therapeutic approaches for systemic lupus erythematosus [J].

Tenbrock, K. .

ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (10) :890-896

[35] New insights into the pathogenesis of systemic lupus erythematosus. [J].

Kyttaris V.C. ;

Katsiari C.G. ;

Juang Y.T. ;

Tsokos G.C. .

Current Rheumatology Reports, 2005, 7 (6) :469-475

[36] Natural killer T cells in families of patients with systemic lupus erythematosus - Their possible role in regulation of IgG production [J].

Green, Matthew R. J. ;

Kennell, Amy S. M. ;

Larche, Maggie J. ;

Seifert, Martin H. ;

Isenberg, David A. ;

Salaman, Myer R. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (01) :303-310

[37] The reduction of circulating invariant natural killer T cells in lupus erythematosus patients is associated with enrichment at the site of cutaneous inflammation [J].

Hofmann, S. C. ;

Bosma, A. ;

Bruckner-Tuderman, L. ;

Isenberg, D. A. ;

Jury, E. ;

Mauri, C. .

EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) :E25-E25

[38] Phenotype and Function of Natural Killer Cells in Systemic Lupus Erythematosus [J].

Hervier, Baptiste ;

Beziat, Vivien ;

Haroche, Julien ;

Mathian, Alexis ;

Lebon, Pierre ;

Ghillani-Dalbin, Pascale ;

Musset, Lucile ;

Debre, Patrice ;

Amoura, Zahir ;

Vieillard, Vincent .

ARTHRITIS AND RHEUMATISM, 2011, 63 (06) :1698-1706

[39] Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus [J].

Serikova, S. Yu. ;

Kozlovskaya, N. L. ;

Shilov, E. M. .

TERAPEVTICHESKII ARKHIV, 2008, 80 (06) :52-58

[40] Systemic Lupus Erythematosus Patients With Atherosclerosis Are Characterised By a Distinct Invariant Natural Killer T Cell Phenotype and Altered CD1d-Mediated Lipid Antigen Presentation [J].

Smith, Edward ;

Croca, Sara ;

Pitcher, Andrew ;

Isenberg, D. A. ;

Rahman, Anisur ;

Jury, Elizabeth C. .

ARTHRITIS AND RHEUMATISM, 2013, 65 :S275-S275

← 1 2 3 4 5 →